Hotchkis & Wiley Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208M Sell
742,022
-1,580
-0.2% -$415K 0.61% 54
2026
Q1
$198M Buy
743,602
+374,664
+102% +$101M 0.61% 50
2025
Q4
$92.6M Sell
368,938
-7,918
-2% -$2.1M 0.28% 80
2025
Q3
$108M Sell
376,856
-7,130
-2% -$1.91M 0.33% 70
2025
Q2
$101M Sell
383,986
-5,188
-1% -$1.26M 0.33% 74
2025
Q1
$90.6M Sell
389,174
-8,656
-2% -$2.1M 0.3% 73
2024
Q4
$91.2M Buy
397,830
+4,950
+1% +$1.14M 0.3% 75
2024
Q3
$87.8M Sell
392,880
-3,892
-1% -$855K 0.29% 76
2024
Q2
$80.7M Buy
396,772
+5
+0% +$1.02K 0.28% 80
2024
Q1
$86.7M Buy
396,767
+385,846
+3,533% +$85M 0.29% 75
2023
Q4
$2.48M Hold
10,921
0.01% 464
2023
Q3
$2.2M Buy
+10,921
New +$2.3M 0.01% 464

Other funds holding LH

Hotchkis & Wiley Capital Management's LH Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management reduced its Labcorp (LH) stake by 0.21% in Q2 2026, selling an estimated $415K and leaving 742,022 shares worth $208M. The position accounts for 0.61% of the portfolio, ranked #54.

Hotchkis & Wiley Capital Management first reported a position in LH in Q3 2023 and has held it in 12 quarters since. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 742,022 shares of Labcorp worth $208M as of Q2 2026.
  • Hotchkis & Wiley Capital Management sold 1,580 Labcorp shares in Q2 2026, an estimated $415K.
  • Labcorp made up 0.61% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #54 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Labcorp in Q3 2023 and has held it in 12 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.